| IFNA1 |
P01562
|
interferon alpha 1
|
|
|
0.371 |
0.923 |
| IFNA13 |
P01562
|
interferon alpha 13
|
|
|
0.374 |
0.923 |
| MIR155 |
|
microRNA 155
|
|
|
0.384 |
0.885 |
| IFNB1 |
P01574
|
interferon beta 1
|
|
|
0.421 |
0.846 |
| LINC01672 |
|
long intergenic non-protein coding RNA 1672
|
|
|
0.462 |
0.846 |
| CBLL2 |
Q8N7E2
|
Cbl proto-oncogene like 2
|
Enzyme
|
|
0.476 |
0.808 |
| ERVW-1 |
Q9UQF0
|
endogenous retrovirus group W member 1, envelope
|
|
|
0.505 |
0.692 |
| MRGPRX3 |
Q96LB0
|
MAS related GPR family member X3
|
G-protein coupled receptor
|
|
0.529 |
0.923 |
| VN1R17P |
Q8TDU5
|
vomeronasal 1 receptor 17 pseudogene
|
|
|
0.529 |
0.923 |
| MRGPRX4 |
Q96LA9
|
MAS related GPR family member X4
|
G-protein coupled receptor
|
|
0.531 |
0.923 |
| MRGPRX1 |
Q96LB2
|
MAS related GPR family member X1
|
G-protein coupled receptor
|
|
0.531 |
0.923 |
| GPR166P |
|
G protein-coupled receptor 166 pseudogene
|
|
|
0.531 |
0.923 |
| ERVK-6 |
|
endogenous retrovirus group K member 6, envelope
|
|
|
0.521 |
0.808 |
| ERVK-32 |
|
endogenous retrovirus group K member 32, envelope
|
|
|
0.522 |
0.692 |
| MIR320A |
|
microRNA 320a
|
|
|
0.526 |
0.808 |
| ERVK-20 |
|
endogenous retrovirus group K member 20
|
|
|
0.533 |
0.692 |
| MIR196B |
|
microRNA 196b
|
|
|
0.561 |
0.731 |
| MIR1246 |
|
microRNA 1246
|
|
|
0.592 |
0.808 |
| ECT |
|
centralopathic epilepsy
|
|
|
0.626 |
0.423 |
| VHLL |
Q6RSH7
|
VHL like
|
|
|
0.682 |
0.385 |
| EGI |
|
epilepsy, generalized, idiopathic
|
|
|
0.861 |
0.077 |
| MYOM2 |
P54296
|
myomesin 2
|
|
7.0E-85 |
0.570 |
0.692 |
| ATM |
Q13315
|
ATM serine/threonine kinase
|
Kinase
|
5.6E-47 |
0.374 |
0.885 |
| SIGLEC1 |
Q9BZZ2
|
sialic acid binding Ig like lectin 1
|
|
5.3E-46 |
0.597 |
0.654 |
| TIMELESS |
Q9UNS1
|
timeless circadian regulator
|
|
9.8E-35 |
0.533 |
0.808 |